Enlivex Therapeutics Ltd (ENLV)

517 +20 (+3.94%)
Close ILS Disclaimer

Enlivex Therapeutics Ltd Company Profile

Equity Type
Enlivex Therapeutics Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. Its product pipeline is the Allocetra, which is in phase II clinical trial for the treatment of organ dysfunction caused by sepsis. The company also develops Allocetra for the treatment of moderate knee osteoarthritis and end-stage knee osteoarthritis which is in phase I/II clinical trial. Enlivex Therapeutics Ltd. is headquartered in Ness Ziona, Israel.
Contact Information
Ness Ziona,7403618 Israel
972 2 670 8072
972 2 670 8070
Top Executives
Abraham Havron 76 2014 Independent Director
Gili Hart 49 2014 Independent Director
Shai Novik 58 2014 Executive Chairman
Roger James Pomerantz 67 2022 Independent Vice Chairman of the Board
Clifford S. Deutschman 0 0000 Clinical Advisor
Brian Schwartz 62 2020 Director
David Hunter 0 2024 Clinical Advisor
Ali Mobasheri 0 2024 Clinical Advisor
Bruno Francois 0 2024 Clinical Advisor
Tobias Winkler 0 2024 Clinical Advisor
Mitchell M. Levy 0 0000 Clinical Advisor
Andrew E. Singer 53 2023 Independent Director
Mervyn Singer 0 2024 Clinical Advisor
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles